Smart science to improve lives™
Russia skyline.

Russia

We are no longer operating in Russia. In 2021, less than 1% of Group sales were to Russia.

We remain hopeful that a peaceful resolution to the conflict can be found.

Further reading

Completed divestment – transitioning to a pure-play Consumer Care and Life Sciences company

Accelerating our transition to a pure-play Consumer Care and Life Sciences company, completion of the divestment of the majority of our Performance Technologies and Industrial Chemicals businesses to...
Danuta Gray

Appointment of Chair Designate

22 September 2023: We are pleased to announce the appointment of Danuta Gray as a Non-Executive Director and Chair Designate

Launch of first report on biotechnology opportunities in the personal care market

27 September 2022: The “Biotechnology: personal care market report” is the first in a series from Croda which aim to help other forward-thinking companies leverage the opportunities offered by...
Laboratory work

UK Government to support expansion of Croda's lipid systems manufacturing facility

31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.